Approvals/HSA/PERGILAS POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL

Approved

THERAPEUTIC

PERGILAS POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL

MEFAR İLAÇ SANAYİİ A.Ş. (PRIMARY & SECONDARY PACKAGER) (TURKEY)🇸🇬 Health Sciences Authority

Approval Id: ec4bb841fdb973f8
Drug Name: PERGILAS POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL
Product Name: PERGILAS POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL
Approval Number: SIN15857P
Approval Date: 2019-11-18
Registrant: RANBAXY (MALAYSIA) SDN. BHD.
Licence Holder: RANBAXY (MALAYSIA) SDN. BHD.
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration: INTRAVENOUS
Atc Code: J02AX04
Atc Item Name: caspofungin
Pharma Manufacturer Name: RANBAXY (MALAYSIA) SDN. BHD.

Caspofungin Acetate 55.52mg equivalent to Caspofungin

50mg/vial

CASPOFUNGIN ACETATE 55.52 MG EQUIVALENT TO CASPOFUNGIN

50 MG/VIAL

Approved

Agency

HSA

Country

🇸🇬

Approval Date

Nov 18, 2019

Approval ID

ec4bb841fdb973f8

Type

Therapeutic